One of the first articles I wrote when I started writing for the ‘Ville three years ago was “Five Rules for Biotech Investing.” With Thomson reporting a surge by individual investors and generalist healthcare funds into biotech, this subject is worth revisiting. I’m also adding a sixth rule that has unfortunately proven true time and time again.